Analysts expect Balchem Co. (NASDAQ:BCPC) to announce $0.69 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Balchem’s earnings. The highest EPS estimate is $0.73 and the lowest is $0.65. Balchem posted earnings of $0.76 per share in the same quarter last year, which suggests a negative year over year growth rate of 9.2%. The firm is expected to issue its next earnings report on Friday, May 3rd.

According to Zacks, analysts expect that Balchem will report full-year earnings of $3.02 per share for the current year, with EPS estimates ranging from $2.89 to $3.15. For the next financial year, analysts expect that the company will report earnings of $3.45 per share, with EPS estimates ranging from $3.30 to $3.60. Zacks Investment Research’s earnings per share calculations are an average based on a survey of analysts that that provide coverage for Balchem.

Balchem (NASDAQ:BCPC) last posted its earnings results on Thursday, February 28th. The basic materials company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.11. Balchem had a return on equity of 14.59% and a net margin of 12.21%. The company had revenue of $163.50 million for the quarter, compared to the consensus estimate of $161.42 million. The business’s quarterly revenue was up 2.6% on a year-over-year basis.

BCPC has been the subject of a number of analyst reports. Zacks Investment Research upgraded Balchem from a “sell” rating to a “hold” rating and set a $94.00 price target for the company in a research report on Monday, February 11th. BidaskClub cut Balchem from a “hold” rating to a “sell” rating in a research report on Friday, March 1st. HC Wainwright set a $101.00 price target on Balchem and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Finally, Seaport Global Securities initiated coverage on Balchem in a research report on Thursday, February 21st. They issued a “neutral” rating for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $105.50.

Institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. grew its position in shares of Balchem by 1.1% during the fourth quarter. BlackRock Inc. now owns 4,697,980 shares of the basic materials company’s stock worth $368,087,000 after purchasing an additional 50,467 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Balchem by 2.6% during the third quarter. Vanguard Group Inc. now owns 3,252,944 shares of the basic materials company’s stock worth $364,622,000 after purchasing an additional 81,119 shares in the last quarter. Vanguard Group Inc grew its position in shares of Balchem by 2.6% during the third quarter. Vanguard Group Inc now owns 3,252,944 shares of the basic materials company’s stock worth $364,622,000 after purchasing an additional 81,119 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in shares of Balchem by 0.8% during the first quarter. Conestoga Capital Advisors LLC now owns 801,988 shares of the basic materials company’s stock worth $74,425,000 after purchasing an additional 6,104 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Balchem by 1.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 746,533 shares of the basic materials company’s stock worth $58,492,000 after purchasing an additional 10,660 shares in the last quarter. Institutional investors and hedge funds own 87.80% of the company’s stock.

BCPC stock traded down $0.02 during trading on Friday, reaching $97.98. The stock had a trading volume of 113,099 shares, compared to its average volume of 104,669. Balchem has a 52 week low of $73.16 and a 52 week high of $117.79. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.94 and a current ratio of 2.76. The company has a market cap of $3.16 billion, a price-to-earnings ratio of 32.55 and a beta of 1.00.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Further Reading: How can investors find ex-dividend dates?

Get a free copy of the Zacks research report on Balchem (BCPC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.